1. Einav, L., Finkelstein, A., & Mahoney, N. (2025). Producing Health: Measuring Value Added of Nursing Homes. Econometrica.

  2. Okeke, E. N. (2026). Making Bricks from Straw: Resources and Productivity in Health Care. American Economic Review.

  3. Lieber, E. M. J., & Lockwood, L. M. (2019). Targeting with In-Kind Transfers: Evidence from Medicaid Home Care. American Economic Review.

  4. Kowalski, A. E. (2023). Reconciling Seemingly Contradictory Results from the Oregon Health Insurance Experiment and the Massachusetts Health Reform. Review of Economics and Statistics.

  5. Finkelstein, A., Taubman, S., Wright, B., et al. (2012). The Oregon Health Insurance Experiment: Evidence from the First Year. The Quarterly Journal of Economics.

  6. Newhouse, J. P. (1989). Do unprofitable patients face access problems? Health Care Financing Review.

  7. Sood, N., Buntin, M. B., & Escarce, J. J. (2008). Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system. Journal of Health Economics.

  8. Gowrisankaran, G., Nevo, A., & Town, R. (2015). Mergers When Prices Are Negotiated: Evidence from the Hospital Industry. American Economic Review.

  9. Prager, E., & Tilipman, N. (2025). Regulating Out-of-Network Hospital Payments: Disagreement Payoffs, Negotiated Prices, and Access.

    Note: Cool paper! Also has useful way to identify OON payments without buying extra data beyond APC

  10. Chandra, A., Finkelstein, A., Sacarny, A., et al. (2016). Health Care Exceptionalism? Performance and Allocation in the US Health Care Sector. American Economic Review.

  11. Finkelstein, A., & McKnight, R. (2008). What did Medicare do? The initial impact of Medicare on mortality and out of pocket medical spending. Journal of Public Economics.

  12. Gruber, J., Howard, D. H., Leder-Luis, J., et al. (2025). Dying or Lying? For-Profit Hospices and End-of-Life Care. American Economic Review.

  13. Vatter, B. (2025). Quality Disclosure and Regulation: Scoring Design in Medicare Advantage. Econometrica.

  14. Cooper, Z., Gibbons, S., & Skellern, M. (2018). Does competition from private surgical centres improve public hospitals' performance? Evidence from the English National Health Service. Journal of Public Economics.

  15. Brot, Z., Cooper, Z., Craig, S. V., et al. (2024). Is There Too Little Antitrust Enforcement in the US Hospital Sector? American Economic Review: Insights.

  16. Dafny, L. S. (2005). How Do Hospitals Respond to Price Changes? American Economic Review.

  17. Dafny, L. S. (2010). Are Health Insurance Markets Competitive? American Economic Review.

  18. Brown, J. R., Coe, N. B., & Finkelstein, A. (2007). Medicaid Crowd-Out of Private Long-Term Care Insurance Demand: Evidence from the Health and Retirement Survey. Tax Policy and the Economy.

  19. Handel, B. R. (2013). Adverse Selection and Inertia in Health Insurance Markets: When Nudging Hurts. American Economic Review.

  20. Brot-Goldberg, Z. C., Chandra, A., Handel, B. R., et al. (2017). What does a Deductible Do? The Impact of Cost-Sharing on Health Care Prices, Quantities, and Spending Dynamics. The Quarterly Journal of Economics.

  21. Shepard, M., & Wagner, M. (2025). Do Ordeals Work for Selection Markets? Evidence from Health Insurance Auto-Enrollment. American Economic Review.

  22. Einav, L., Finkelstein, A., & Schrimpf, P. (2015). The Response of Drug Expenditure to Nonlinear Contract Design: Evidence from Medicare Part D. The Quarterly Journal of Economics.

  23. Heim, B. T., Hunter, G., Isen, A., et al. (2021). Income Responses to the Affordable Care Act: Evidence from a Premium Tax Credit Notch. Journal of Health Economics.

  24. Yelowitz, A. S. (1995). The Medicaid Notch, Labor Supply, and Welfare Participation: Evidence from Eligibility Expansions. The Quarterly Journal of Economics.

  25. Ho, K., & Lee, R. S. (2017). Insurer Competition in Health Care Markets. Econometrica.

  26. Andreyeva, E., Gupta, A., Ishitani, C., et al. (2024). The Corporatization of Independent Hospitals. Journal of Political Economy Microeconomics.

  27. Gupta, A., La Forgia, A., & Sacarny, A. (2026). Turbocharging Profits? Contract Gaming and Revenue Allocation in Healthcare. American Economic Journal: Applied Economics.

  28. Kuziemko, I., Meckel, K., & Rossin-Slater, M. (2018). Does Managed Care Widen Infant Health Disparities? Evidence from Texas Medicaid. American Economic Journal: Economic Policy.

  29. Van Houtven, C. H., Coe, N. B., & Skira, M. M. (2013). The effect of informal care on work and wages. Journal of Health Economics.

  30. Coe, N. B., & Zamarro, G. (2011). Retirement effects on health in Europe. Journal of Health Economics.

  31. Coe, N. B., von Gaudecker, H., Lindeboom, M., et al. (2011). The Effect of Retirement on Cognitive Functioning. Health Economics.

  32. Einav, L., Finkelstein, A., Oostrom, T., et al. (2020). Screening and Selection: The Case of Mammograms. American Economic Review.

  33. Giles, T., Hungerman, D., & Oostrom, T. (2025). Deaths of Despair and the Decline of American Religion. Journal of the European Economic Association.

  34. Oostrom, T. (2024). Funding of Clinical Trials and Reported Drug Efficacy. Journal of Political Economy.

  35. Sacks, D. W., Hollingsworth, A., Nguyen, T., et al. (2021). Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. Journal of Health Economics.

  36. Kao, J. (2025). Information Disclosure and Competitive Dynamics: Evidence from the Pharmaceutical Industry. Management Science.

  37. Ho, K., & Lee, R. S. (2026). Contracting Over Pharmaceutical Formularies and Rebates. Econometrica.

    Note: Someday, I'll understand the significance of this paper instead of just going "woah." Today is not that day.

  38. Budish, E., Roin, B. N., & Williams, H. (2015). Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials. American Economic Review.

  39. Gray, C., Alpert, A., & Sood, N. (2026). Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market. American Economic Journal: Applied Economics.

  40. Alpert, A., Powell, D., & Pacula, R. L. (2018). Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids. American Economic Journal: Economic Policy.

  41. Alpert, A., Evans, W. N., Lieber, E. M. J., et al. (2021). Origins of the Opioid Crisis and its Enduring Impacts. The Quarterly Journal of Economics.

  42. Alsan, M., & Wanamaker, M. (2017). Tuskegee and the Health of Black Men. The Quarterly Journal of Economics.

  43. Abaluck, J., Caceres Bravo, M., Hull, P., et al. (2021). Mortality Effects and Choice Across Private Health Insurance Plans. The Quarterly Journal of Economics.

  44. Barrette, E., Dafny, L., & Shen, K. (2023). Do Policies to Increase Access to Treatment for Opioid Use Disorder Work? American Journal of Health Economics.

  45. Serna, N. (2025). Exogenous Exits, Market Structure, and Equilibrium Contracts in Health Care. American Economic Review: Insights.

  46. Wallace, J. (2023). What Does a Provider Network Do? Evidence from Random Assignment in Medicaid Managed Care. American Economic Journal: Economic Policy.